This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

South Korea, Seoul


The primary office of this Corporate Investor is located in Seoul. This investor is located in Asia, South Korea.

The average start-up age at the time of investment by this fund is 1 and less. The country of its foundation and the country of its most frequent investments doesn't coincide - United States. Besides this, the fund also invested in 1 other country. We can highlight the most popular investment areas for this fund, such as Biotechnology, Supply Chain Management. In addition, there are 8 more industries where it has achieved success. The fund has no an exact preference in the amount of founders of companies in its portfolio. ImpriMed, Luxstay are among the most popular portfolio start-ups of the fund.

The fund usually invests in rounds together with 4 others. Besides Nextrans, start-ups are typically funded by Plug and Play, Pear Ventures, Genesia Ventures. The most common co-investors for the fund are Bon Angels Venture Partners, Y1 Ventures, Viet Capital Ventures. The investors in the following rounds are usually CyberAgent Capital, Bon Angels Venture Partners, Y1 Ventures.

Typical investments for this fund are deals in the range of 1 - 5 millions dollars. This fund was the most active in 2018. Besides, in 2019 the fund was active. At the time of investment by Nextrans, a typical start-up valuation would be 1-5 millions dollars. The fund usually participates in less than 2 investment rounds per year.

Fund Activity


Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing in Previous

Plug and Play, Pear Ventures, Genesia Ventures

Funds Investing in Following

CyberAgent Capital, Bon Angels Venture Partners, Y1 Ventures

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: